📰 Primary Biliary News
Page 3 - Primary Biliary News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Primary Biliary. Real-time updates on events, politics, business and more.
May 4, 2022
The "Primary Biliary Cirrhosis Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This "Primary Biliary Cirrhosis Epidemiology Forecast to 2032" report delivers
March 1, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
January 11, 2022
Crohn’s disease (CD) Market Outlook, Epidemiology, Competitive Landscape & Market Forecast Report – 2020 to 2030
January 11, 2022
Crohn’s disease (CD) Market Outlook, Epidemiology, Competitive Landscape & Market Forecast Report – 2020 to 2030
January 10, 2022
/PRNewswire/ -- COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders, today announced...
January 10, 2022
/PRNewswire/ -- COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders, today announced...
June 26, 2021
Drinking 3 to 4 cups of coffee a day reduces risk of liver cancer, study suggests By Catherine Park A recent study shows there may be a positive link between coffee consumption and bone health. A new study suggests people who drink between three to four cups of coffee a day are less likely to develop cancer or other severe illnesses as a result of chronic liver disease (CLD) as opposed to those who do not drink it. The study, published on June 22 in BMC Public Health, a peer-reviewed journal ...
January 28, 2021
Read more about Cadila Healthcare rises after USFDA grants orphan drug designation for Saroglitazar Mg on Business Standard. Cadila Healthcare rose 0.69% to Rs 465.40 after the company was granted orphan drug designation by the US drug regulator for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis (PBC).